Moderna Says Health Canada Authorizes mFLUSIVA And mCOFLU For Adults 50 Years Of Age And Older
Canada becomes the first country to authorize both Moderna's mRNA seasonal influenza vaccine, mFLUSIVA®, and combination influenza and COVID-19 vaccine, mCOFLU®CAMBRIDGE, MA / ACCESS Newswire / November 5, 2026 /
Canada approved two new Moderna vaccines for older adults. When companies get new approvals, it shows their science works and might bring in new sales.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.